Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Oncology|February 5, 2020
The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response predictionPaul van der Leest, Ed Schuuring
Clinical Chemistry|January 4, 2024
Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular ProfilingPaul van der Leest, Ed Schuuring
International Journal of Molecular Sciences|August 28, 2025
Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative StudyPim Rozendal, Hanneke Kievit, Paul van der Leest, et al.
Cancers|October 21, 2020
Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison StudyPierre-Jean Lamy, Paul van der Leest, Nicolas Lozano, et al.
Cancers|May 17, 2020
Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer PatientsPaul van der Leest, Pieter A Boonstra, Arja Ter Elst, et al.
Molecular Oncology|August 27, 2021
Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitorsPaul van der Leest, Birgitta Hiddinga, Anneke Miedema, et al.
Cell Reports. Medicine|December 17, 2025
CfDNA-based copy-number dynamics during anti-PD1 treatment in metastatic triple negative breast cancerAaron Y Lin, Olga I Isaeva, Teoman Deger, et al.
Targeted Oncology|June 5, 2025
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose OsimertinibFenneke Zwierenga, M Benthe Muntinghe-Wagenaar, Pim Rozendal, et al.
International Journal of Molecular Sciences|September 9, 2023
Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer PatientsPaul van der Leest, Melanie Janning, Naomi Rifaela, et al.
Clinical Chemistry|January 16, 2023
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal AdenocarcinomaChristine Nitschke, Benedikt Markmann, Philipp Walter, et al.
Pageof 2